SCHEMBL24118372

SCHEMBL24118372

O=CCC12CC(NC(=O)c3ccc(F)c(F)c3)(C1)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.49
▸ TAS1R3 Q7RTX0 1/20 0.41
▸ TAS1R1 Q7RTX1 1/20 0.41
▸ TAS1R2 Q8TE23 1/20 0.41
▸ CES2 O00748 1/20 0.40
▸ CES1 P23141 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ STS P08842 1/20 0.38
▸ KCNQ3 O43525 5/20 0.38
▸ KCNQ2 O43526 5/20 0.38
▸ KCNQ5 Q9NR82 1/20 0.37
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ KCNE1 P15382 1/20 0.36
▸ KCNQ1 P51787 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CASP3 P42574 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21504218 0.80 IDO1 (0.51) IDO1NPC1RAB9A
SCHEMBL21496341 0.79 IDO1 (0.53) IDO1TAS1R3TAS1R1TAS1R2CES2
SCHEMBL24118369 0.77 IDO1 (0.46) IDO1TAS1R3TAS1R1TAS1R2CES2
SCHEMBL29460313 0.76 IDO1 (0.52) IDO1TAS1R3TAS1R1TAS1R2CES2
SCHEMBL21504281 0.74 TAS1R3 (0.49) TAS1R3TAS1R1TAS1R2CES2CES1
SCHEMBL19556221 0.67 ATF4 (0.65) —
SCHEMBL29717191 0.67 CES2 (0.59) TAS1R3TAS1R1TAS1R2CES2CES1
SCHEMBL1128282 0.67 CES2 (0.59) TAS1R3TAS1R1TAS1R2CES2CES1
SCHEMBL31079848 0.67 CES2 (0.46) IDO1TAS1R3TAS1R1TAS1R2CES2
SCHEMBL21504283 0.67 TAS1R3 (0.49) IDO1TAS1R3TAS1R1TAS1R2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors MERCK SHARP & DOHME CORP. (US) 2021-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors IDO1, IDO2, TPH1 IDO1 1/4885TAS1R3 4634/4885TAS1R1 4287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback